SteriPlas to be presented at the DFSG conference
Adtec looks forward to supporting Ms Jemma Cruickshank, Antimicrobial Pharmacy Technician from Kettering General Hospital NHS Foundation Trust, at the Diabetic Foot Study Group (DFSG) conference in September.
Jemma has been invited to present the “Retrospective review of the use of argon cold plasma therapy in non-healing diabetic foot ulcers over a 3-year period within a DGH Diabetic Foot MDT Service” at the conference.
Her presentation will include the strong benefits of the SteriPlas on chronic and large diabetic foot ulcers prone to biofilm infections.
The abstract for this presentation can be found here: https://distribute.m-anage.com/from.storage?image=erIsXlaDuNOv64Tv4JyKY6XW3cI1HigkZNgT5cOgYv7Vzt_UHvGbDPesijzVroVO0
For more information about our SteriPlas Premium Cold Plasma medical device, send us an email info@adtecplasma.com
Upcoming Exhibitions for 2024
Adtec looks forward to exhibiting at the Diabetic Foot Study Group (DFSG) conference between 6-8 September and the European Mechanical Support Summit (EUMS) conference between 11-14 September. At both conferences, we will have our SteriPlas Premium Cold Plasma medical device on our booth for a live demonstration. The SteriPlas boasts a strong clinical evidence collection of 80+ clinical trials and studies across a multitude of infection conditions.
To better understand our medical device and the positive imprint we have made on the severe infection conditions, please visit our booth during the two shows to see the SteriPlas in person.
Day 2 of the Malvern Diabetic Foot Conference
Day 2 of the Malvern Diabetic Foot Conference 2024. Don't forget to visit us to see how Premium Cold Plasma SteriPlas has healed chronic diabetic foot ulcers.
Day 2 of EWMA 2024
Day 2 of the European Wound Management Association (EWMA) exhibition. Visit us at booth G70 to see our Premium Cold Plasma live in action. With the strongest clinical efficacy for the infection management in wounds, surgical site infections and medical dermatology.
Day 1 of EWMA 2024
Day 1 of the European Wound Management Association (EWMA) exhibition. We have enjoyed catching up with friends and meeting new people interested in our Premium Cold Plasma medical device. Our Clinical Bibliography of 80+ clinical trials and studies puts us at the forefront of Cold Plasma Medicine for wounds, surgical site infections and medical dermatology. Visit us at booth G70 to learn more.
EWMA 2024
We look forward to exhibiting at the European Wound Management Association (EWMA) exhibition next week. Positioned at booth #G70, our Premium Cold Plasma medical device, the SteriPlas, will be featured to the public. Adtec Healthcare Cold Plasma company can boast of having very strong clinical trials data amongst a total of 80+ peer reviewed studies. Our medical device has proven anti-biofilm efficacy in chronic infections within wounds, surgical site infections and medical dermatology conditions.
Day 1 of the ISHLT
An exciting start to the ISHLT 2024 show. Our SteriPlas Premium Cold Plasma medical device is being widely spoken about throughout the sessions and we welcome you to visit our booth no.12 to learn more.
Adtec to exhibit at the ISHLT show
We are excited to be exhibiting at the ISHLT show next week. Our team will be onsite at booth no. 12 ready to welcome you and introduce you to our SteriPlas Premium Cold Plasma medical device used for the treatment of LVAD infections complicated with biofilm. Many of our customers will also be at the show who would be happy to give you a demonstration of our SteriPlas or to explain the strong clinical efficacy observed when using our medical device.
If you would like to secure a meeting in advance, please contact us at info@adtecplasma.com
Adtec joins the Innovation Platform at LSI 2024
We look forward to participating at the Innovation Platform at the @LSI USA 2024. Our CEO, Mary McGovern, will be in the Private Partnering Area between 18-22 March 2024 meeting with exclusive Medtech and Healthtech leaders to bring the rich content of the SteriPlas Premium Cold Plasma to them.
The SteriPlas is renowned for its proven clinical efficacy destroying chronic and complicated biofilm within infected wounds and surgical site infections. Our wide clinical bibliography of 80+ clinical trials and studies ranges from diabetic foot ulcers, LVAD infections, Sternal wound infections and so on.
Delivering a unique physical mode of action during treatment, the SteriPlas dense Cold Plasma ensures the total destruction of all bacterial species protected within biofilm which would otherwise have been resistant to antibiotics. Essentially, we are saving limbs !
We have documented the cost savings benefit due to be published this year across two separate papers focused on diabetic foot ulcers and sternal wound infections.
Our purpose of the LSI Innovation Platform attendance is to seek the potential of investment to help bring our medical device to new territories that have yet to benefit from what we can offer.
Cold Plasma is changing the norm of modern medicine.
Arab Health Exhibition 2024
We’re excited to be attending the Arab Health Exhibition next week to meet with our new partners across the Middle East. This year Adtec Healthcare Limited welcomes the expansion of our Cold Plasma to the MENA region, facilitated by our Distributors in their leading fields of wound care and surgical site infections.
If you would like to secure your meeting with us during the Arab Health show, please send us an email at info@adtecplasma.com